Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Amgen
Amgen
Amgen (AMGN) Q3 2025 Earnings Call Transcript
By
Fortune Editors
November 4, 2025
Amgen (AMGN) Q2 2025 Earnings Call Transcript
By
Fortune Editors
August 5, 2025
Amgen (AMGN) Q1 2025 Earnings Call Transcript
By
Fortune Editors
May 1, 2025
Amgen (AMGN) Q4 2024 Earnings Call Transcript
By
Fortune Editors
February 4, 2025
Conferences
AI is in the early stages of upending the drug discovery and development process, but there will still need to be a ‘lab in the loop’
By
Sage Lazzaro
December 14, 2023
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By
Arthur Allen
and
KFF Health News
April 13, 2023
Magazine
Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
By
Geoff Colvin
April 8, 2021
Newsletters
Inclusion in the Dow does not guarantee a bump to your share price
By
Katherine Dunn
and
Alan Murray
August 27, 2020
Newsletters
Can the Dow’s Big Tech makeover finally push the blue chip index above 30,000?
By
Bernhard Warner
August 25, 2020
Finance
Salesforce, Amgen, and Honeywell Int’l will join Dow Jones Industrial Average
By
Andrew Nusca
August 24, 2020
Conferences
Amgen CEO is ‘optimistic’ about COVID-19 clinical trials
By
Aaron Pressman
July 7, 2020
Newsletters
U.S. Biotech Amgen Strikes Major Deal to Expand China Presence
By
Sy Mukherjee
October 31, 2019
Health
3 Drug Giants Win a Legal Victory Against Trump—For Now: Brainstorm Health
By
Sy Mukherjee
July 9, 2019
Health
Big Drug Makers Sue to Block Mandatory Price Disclosures in TV Ads: Brainstorm Health
By
Sy Mukherjee
June 14, 2019
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By
David Meyer
May 18, 2018
Most Popular
North America
Jeff Bezos and Lauren Sánchez Bezos commit $102.5 million to organizations combating homelessness across the U.S.:...
By
Sydney Lake
Economy
Ford workers told their CEO 'none of the young people want to work here.' So Jim Farley took a page out of the...
By
Sasha Rogelberg
North America
Anonymous $50 million donation helps cover the next 50 years of tuition for medical lab science students at University...
By
The Associated Press